Cargando…
Hepatocarcinogenesis in transgenic mice carrying hepatitis B virus pre-S/S gene with the sW172* mutation
Hepatitis B virus (HBV) carrying the rtA181T/sW172* mutation conferred cross-resistance to adefovir and lamivudine. Cell-based and clinical studies indicated that HBV carrying this mutation had an increased oncogenic potential. Herein, we created transgenic mouse models to study the oncogenicity of...
Autores principales: | Lai, M-W, Liang, K-H, Lin, W-R, Huang, Y-H, Huang, S-F, Chen, T-C, Yeh, C-T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177775/ https://www.ncbi.nlm.nih.gov/pubmed/27918551 http://dx.doi.org/10.1038/oncsis.2016.77 |
Ejemplares similares
-
Biological characteristics of the rtA181T/sW172* mutant strain of Hepatitis B virus in animal model
por: Dai, Jie, et al.
Publicado: (2012) -
Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B
por: Yeh, Chau-Ting, et al.
Publicado: (2011) -
Hepatocarcinogenesis in Transgenic Mice Carrying Albumin‐promoted SV40 T Antigen Gene
por: Hino, Okio, et al.
Publicado: (1991) -
Transgenic Expression of Entire Hepatitis B Virus in Mice Induces Hepatocarcinogenesis Independent of Chronic Liver Injury
por: Na, Bing, et al.
Publicado: (2011) -
Infection with hepatitis B virus carrying novel pre-S/S gene mutations in female siblings vaccinated at birth: two case reports
por: Lai, Ming-Wei, et al.
Publicado: (2010)